381 results on '"Doranz, Benjamin J."'
Search Results
2. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
3. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
4. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
5. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
6. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
7. Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
8. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
9. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
10. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
11. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
12. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
13. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
14. Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles
15. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
16. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
17. Mxra8 is a receptor for multiple arthritogenic alphaviruses
18. Abstract 2646: Screening the membrane proteome to determine antibody specificity and de-risk CAR-T cell development
19. Differential Utilization of CCR5 by Macrophage and T Cell Tropic Simian Immunodeficiency Virus Strains
20. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
21. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
22. A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor
23. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
24. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
25. RETRACTED: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
26. Atomic-level functional model of dengue virus Envelope protein infectivity
27. Abstract 317: Isolation of highly selective antibodies against claudin 18.2 for the treatment of solid tumors
28. Abstract 318: Atomic-level specificity of Claudin 6 monoclonal antibodies isolated for treating solid tumors
29. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function
30. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
31. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8⁺ T cells
32. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection
33. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
34. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
35. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
36. Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
37. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
38. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
39. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
40. Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
41. Cell-Free Assay of G-Protein-Coupled Receptors Using Fluorescence Polarization
42. A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes
43. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies
44. Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
45. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
46. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
47. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
48. Abstract 5688: IND-enabling characterization of ONC206 as the next bitopic antagonist for oncology
49. Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
50. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.